• Best Practices New Normal
  • Digital Dentistry
  • Data Security
  • Implants
  • Catapult Education
  • COVID-19
  • Digital Imaging
  • Laser Dentistry
  • Restorative Dentistry
  • Cosmetic Dentistry
  • Periodontics
  • Oral Care
  • Evaluating Dental Materials
  • Cement and Adhesives
  • Equipment & Supplies
  • Ergonomics
  • Products
  • Dentures
  • Infection Control
  • Orthodontics
  • Technology
  • Techniques
  • Materials
  • Emerging Research
  • Pediatric Dentistry
  • Endodontics
  • Oral-Systemic Health

How Trump's Views on Financial Regulations Affect Your Investments

Article

What now for the DOL fiduciary rule that takes effect this coming April?

If you want to make a dentist’s eyes glaze over, just try mentioning somewhat obscure executive branch rule-making. But the simple truth is that the president-elect is likely to attempt to reverse or revise several policies and procedures set in motion by the current administration.

For the remainder of the year, we’ll be looking at the possible implications of a Donald Trump presidency, particularly as they may affect dentists as professionals and investors. Today, let’s consider what the election result may mean for legislation passed earlier this year and summarized here: the Department of Labor’s (DOL) “conflict of interest” rule.

In short, the rule was designed to strengthen protections for investors by requiring that registered investment advisors and other persons act solely in the best interests of their customers in making investment recommendations—avoiding conflicts of interests and operating with full transparency.

What happens now?

The President-elect hasn’t spoken directly about the DOL rule, so it’s not entirely certain whether or not the rule could be reversed, modified, or perhaps simply delayed. In fact, financial services firms likely to be affected most heavily by the rule are proceeding full steam ahead as if the rule’s provisions will in fact take place, as scheduled in April 2017 for some aspects of rule and by January 1, 2018 for full implementation.

But the rule itself is considered “industry-unfriendly,” so there is always the possibility that it will look different 6 months from now.

Why this matters to you as an investor

If the rule stays intact, investors may see some differences in how they work with advisors and the kinds of investment vehicles—and advice—offered to them. For example, the new rule as written includes significant enhancements to disclosure requirements, which means investment advisors will have to adjust their business models. Many transactions that used to be simple and straightforward will now come with a heap of disclosure documents investors will have to look through and sign. Certain products, such as variable annuities, may become too costly for advisors to profitably sell, due to the reductions in fees many will likely see and the increases in disclosure requirements. This may mean advisors simply won’t work as closely with investors of modest means, as the profit margin in doing so will now be lower. This may not affect dentists as much as lower earners, but it could.

There are no actions for investors to take now. But you’ll want to stay tuned for news about the impact of the rule. Beyond just your status as an investor, how the new administration handles the rule may be an indicator of how President Trump will try to tackle larger fish that could impact your practice, such as the Affordable Care Act, which Trump has vowed to dismantle.

Photo courtesy of Gage Skidmore.

Related Videos
2024 Dental Products Report Spring Selection Bracket Reveal Video
Process of Care Workflow and Repairing Early Caries with Guided Enamel Remineralization
Addressing Unmet Needs in Early Childhood Oral Care - an interview with Ashlet Lerman, DDS
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: Ivoclar's e.max ZirCAD Prime Blocks with Shashi Singhal, BDS, MS
CDS 2024: Diving Deep on J. Morita's New Root ZX3 & HF Module
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
Related Content
© 2024 MJH Life Sciences

All rights reserved.